Home Newsfeeds Dawson James Downgrades BioCardia to Neutral

Dawson James Downgrades BioCardia to Neutral

Dawson James analyst Jason Kolbert downgrades BioCardia (NASDAQ:BCDA) from Buy to Neutral.

byBenzinga Newsdesk

November 11, 2022

1 minute read

Dawson James analyst Jason Kolbert downgrades BioCardia (NASDAQ:BCDA) from Buy to Neutral.

News

Hepsiburada Disclosed The Six-month Result Of The ‘Trade And Technology Empowerment For The Earthquake Region’ Program, With Active Merchants Operating In The Earthquake Region Reaching 15,000

By Benzinga Newsdesk

October 5, 6:48 AM

Since the program's launch in March 2023: The total number of active merchants operating in the earthquake region has reached 15,000, with 1,700 new businesses selling their products online

HEPS

Inhibrx Announces Updated Efficacy And Safety Data From The Expansion Cohorts In The Phase 1 Trial Of INBRX-109 For The Treatment Of Chondrosarcoma

By Benzinga Newsdesk

November 16, 10:02 AM

Inhibrx, Inc. (NASDAQ:INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, today announced updated efficacy and safety data from the ongoing

INBX

Jack Dorsey Says Ethereum A Security, Believes ‘Bitcoin Way Too Ahead Amid SEC Lawsuits Against Binance, Coinbase

By Mehab Qureshi

June 6, 11:54 PM

The former CEO of Twitter, Jack Dorsey believes that Ethereum (CRYPTO: ETH) is a security. What Happened: Dorsey was responding to a Twitter user who asked Dorsey "is ETH a security." To which, Dorsey said "Yes".

BTC